These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 17087944

  • 1. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E, Delgado M.
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic action of ghrelin in a mouse model of colitis.
    Gonzalez-Rey E, Chorny A, Delgado M.
    Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
    [Abstract] [Full Text] [Related]

  • 3. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C, Martinez C, Juarranz MG, Arranz A, Leceta J, Delgado M, Gomariz RP.
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [Abstract] [Full Text] [Related]

  • 5. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
    Zuo L, Huang Z, Dong L, Xu L, Zhu Y, Zeng K, Zhang C, Chen J, Zhang J.
    Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
    [Abstract] [Full Text] [Related]

  • 6. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C.
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [Abstract] [Full Text] [Related]

  • 7. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
    Van Montfrans C, Rodriguez Pena MS, Pronk I, Ten Kate FJ, Te Velde AA, Van Deventer SJ.
    Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M.
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [Abstract] [Full Text] [Related]

  • 9. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
    Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martínez C.
    Ann N Y Acad Sci; 2006 Jul; 1070():129-34. PubMed ID: 16888154
    [Abstract] [Full Text] [Related]

  • 10. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E, Delgado M.
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [Abstract] [Full Text] [Related]

  • 11. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
    Chorny A, Gonzalez-Rey E, Delgado M.
    Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
    [Abstract] [Full Text] [Related]

  • 12. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
    Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M.
    Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
    [Abstract] [Full Text] [Related]

  • 13. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E, Chorny A, Varela N, O'Valle F, Delgado M.
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [Abstract] [Full Text] [Related]

  • 15. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM.
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [Abstract] [Full Text] [Related]

  • 16. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M, Huang MC, Goetzl EJ.
    Cell Immunol; 2011 Jan; 267(2):124-32. PubMed ID: 21295288
    [Abstract] [Full Text] [Related]

  • 17. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D, Anderson P, Gonzalez-Rey E.
    J Immunol; 2009 Oct 01; 183(7):4346-59. PubMed ID: 19734220
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease.
    Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M.
    Gut; 2006 Jun 01; 55(6):824-32. PubMed ID: 16401687
    [Abstract] [Full Text] [Related]

  • 19. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.
    Arthritis Rheum; 2009 Apr 01; 60(4):1006-19. PubMed ID: 19333946
    [Abstract] [Full Text] [Related]

  • 20. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E, Waks T, Eshhar Z.
    Gastroenterology; 2008 Jun 01; 134(7):2014-24. PubMed ID: 18424268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.